As one of the world’s first fetal surgeons, Diana Farmer has long been focused on the smallest of patients.
She specializes in treating birth defects inside and outside of the womb, treating congenital anomalies and cancer and performing airway and intestinal surgeries. In the late 1990s, she became the first woman in the world to perform open fetal surgery.
Drs. Boaz Arzi and Maria Soltero-Rivera of the Dentistry and Oral Surgery Service recently attended the American Association for Advancement of Science (AAAS) annual conference where they presented on stem cell and other regenerative medicine therapies.
Dr. Soltero-Rivera presented the poster “Distinctive Characteristics of Extracellular Vesicles from Naïve and Cytokine-Stimulated Feline Adipose- and Placenta-Derived Stromal Cells” on her groundbreaking work with stem cells and regenerative medicine.
Collaborative and translational research is a cornerstone of advancing the science of veterinary medicine at UC Davis. Three scientists at the university are taking regenerative medicine to new heights.
Thanks to a university-wide collaboration between veterinarians, physicians, researchers, and biomedical engineers, a groundbreaking clinical trial has been approved in human medicine to treat spina bifida with stem cells.
Since 2012, the Veterinary Institute for Regenerative Cures (VIRC) at the UC Davis School of Veterinary Medicine (SVM) has been committed to transforming the SVM into a national leader for veterinary regenerative medicine. VIRC has established laboratory techniques and animal models that have been used to study regenerative therapies for veterinary and human medicine. It has characterized equine, canine and feline stem cells isolated from different tissues with a focus on adult-derived mesenchymal stem cells.
